A Pandemic Declare by World Health Organization: COVID-19

Science Press Release Distribution Services

A Pandemic Declare by World Health Organization: COVID-19

September 6, 2021 Pharmaceutical 0

SARS-CoV-2, now known as 2019-nCoV), a novel coronavirus that causes the coronavirus illness 2019 (COVID-19), has lately spread over the world, beginning in China and then spreading to other parts of the globe. The World Health Organization (WHO) proclaimed the COVID-19 outbreak a public health emergency of worldwide concern on January 30, 2020, following its spread in China. SARS-CoV-2, which emerged in the twenty-first century and was followed by the Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012, produced severe acute respiratory syndrome. It was also known as the extremely virulent and large-scale epidemic coronavirus that caused widespread human injury. According to WHO figures released on March 1, 2020, a total of 87,137 cases have been confirmed worldwide, including 79,968 cases in China and 2977 deaths (3.4%). Following that, researchers determined that SARS-CoV-2 is a member of the b-coronavirus family, which shares a genome with bat coronavirus, indicating that bats are the virus’s natural host. The novel coronavirus spreads predominantly through the respiratory system and exploits the same receptor as SARS-CoV, angiotensin-converting enzyme 2 (ACE2). The COVID-19 virus has a long history of human-to-human transmission all throughout the world. The most prevalent clinical symptoms displayed by the majority of the patients were fever, dry cough, exhaustion, difficulty breathing, and, less commonly, gastrointestinal problems. COVID-19 infection, as well as catastrophic effects such as acute respiratory distress syndrome (ARDS) and cytokine storm, are more common among the elderly and those with underlying illnesses such as heart disease, diabetes, cancer, or kidney disease. There are currently few specific antiviral therapies available, but several drug regimens and other antibody-based research are being investigated. COVID-19’s epidemiology, aetiology, and clinical characteristics, as well as current treatment options and future scientific developments to combat the epidemic new coronavirus, are summarised in this article.

Author (S) Details

Ashwini Arun Zanke
Shri Sant Gajanan Maharaj College of Pharmacy, Buldhanan, India.

Raju R. Thenge
Dr Rajendra Gode College of Pharmacy, Malkapur, Maharashtra, India.

Vaibhav S. Adhao
Dr Rajendra Gode College of Pharmacy, Malkapur, Maharashtra, India.

View Book :- https://stm.bookpi.org/TIPR-V11/article/view/3127

 

Leave a Reply

Your email address will not be published. Required fields are marked *